StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > warrants

<< Previous

Bullboard Posts

Next >>

Comment by okletsmakemoneyon Jan 22, 2021 5:37pm

168 Views

Post# 32362477

RE:RE:warrants

Each Unit will be offered at a price of $0.07 per Unit (the "Offering Price") and will be comprised of one common share of the Company (a "Common Share") and one common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.09 for a period of 36 months following the closing date of the Offering

Is the strike price 9cents x 8 = 72cents?
So, 8 warrants + 72 cents = 1 common share.
please correct me if I'm wrong. Thank you.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?